HARBOURVEST PARTNERS LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 90 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$92,987
-7.6%
5,6390.0%0.03%
-23.5%
Q1 2023$100,600
-86.8%
5,639
-88.8%
0.03%
-90.8%
Q1 2020$764,000
-33.7%
50,2210.0%0.37%
-22.3%
Q4 2019$1,153,000
+6.4%
50,2210.0%0.48%
+5.3%
Q3 2019$1,084,000
-51.0%
50,221
-50.0%
0.45%
+9.2%
Q2 2019$2,210,000
+60.5%
100,442
+100.0%
0.41%
-15.2%
Q1 2019$1,377,00050,2210.49%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders